Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

International Clinical Psychopharmacology

Volumn 23, Issue 2, 2008, Pages 106-109

  Sclar, David A ^a,b   Robison, Linda M ^a   Skaer, Tracy L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Washington Institute for Mental Illness Research and Training   (United States)

Author keywords

Antidepressants; Depression; Ethnicity; National Ambulatory Medical Care Survey; Race; Trends

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; DEPRESSION; DRUG USE; ETHNIC DIFFERENCE; ETHNICITY; HEALTH BEHAVIOR; HEALTH CARE; HEALTH CARE DELIVERY; HELP SEEKING BEHAVIOR; HUMAN; INCIDENCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; ANTIDEPRESSIVE AGENTS; CONTINENTAL POPULATION GROUPS; DEPRESSION; DRUG UTILIZATION; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; UNITED STATES;

EID: 39849084354     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e3282f2b3dd     Document Type: Article

References (20)

1. Bryant E, Shimizu I (1988). Sampling design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey. National Center for Health Statistics. Vital Health Stat 2:1-39.
2. Diala C, Muntaner C, Walrath C, Nickerson KJ, LaVeist TA, Leaf PJ (2000). Racial differences in attitudes toward professional mental healthcare and in the use of services. Am J Orthopsychiatry 70:455-464.
3. Food and Drug Administration (1995). National Drug Code Directory, 1995 edition. Washington: Public Health Service.
4. Koch H, Campbell W (1982). The collection and processing of drug information. National Ambulatory Medical Care Survey, 1980. National Center for Health Statistics. Vital Health Stat 2:1-90.
5. Mojtabai R, Olfson M (2006). Treatment seeking for depression in Canada and the United States. Psychiatr Serv 57:631-639.
6. Melfi CA, Croghan TW, Hanna MP, Robinson RL (2000). Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry 61:16-21.
7. National Center for Health Statistics: National Ambulatory Medical Care Surveys, 1992-1997, 2003-2004. Microdata available at: www.cdc.gov/nchs/about/ major/ahcd/ahcd1.htm.
8. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA (2002). National trends in the outpatient treatment of depression. JAMA 287:203-209.
9. Public Health Service and Health Care Financing Administration (1989). International classification of diseases, 9th revision, clinical modification. Vol. 1. DHHS publication no. (PHS) 89-1260. Washington: Public Health Service.
10. Sclar DA, Robison LM, Skaer TL, Galin RS (1998a). Antidepressant prescribing patterns: a comparison of blacks and whites in a Medicaid population. Clin Drug Invest 16:135-140.
11. Sclar DA, Skaer TL, Robison LM, Galin RS, Legg RF, Nemec NL (1998b). Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis. J Clin Psychiatry 59 (Suppl 2):13-17.
12. Sclar DA, Robison LM, Skaer TL, Galin RS (1999a). Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995. Harv Rev Psychiatry 7:29-36.
13. Sclar DA, Skaer TL, Robison LM, Galin RS (1999b). Economic appraisal of citalopram in the management of single-episode depression. J Clin Psychopharmacol 19 (Suppl 1):47S-54S.
14. Simpson SM, Krishnan LL, Kunik ME, Ruiz P (2007). Racial disparities in diagnosis and treatment of depression: a literature review. Psychiatr Q 78: 3-14.
15. Skaer TL, Sclar DA, Robison LM, Galin RS (2000a). Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US: an assessment of office-based visits 1990 to 1998. CNS Drugs 14:473-481.
16. Skaer TL, Sclar DA, Robison LM, Galin RS (2000b). Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race. An assessment of office-based visits in the United States, 1992-1997. Clin Ther 22:1575-1589.
17. Skaer TL, Sclar DA, Robison LM, Galin RS (2000c). The need for an iterative process for assessing economic outcomes associated with selective serotonin reuptake inhibitors. PharmacoEconomics 18:205-214.
18. US Census Bureau (a). National population estimates for the 1990's. Monthly postcensal resident population, by single year of age, sex, race, and Hispanic origin. Internet release date: June 30, 2000; http://www.census.gov/ population/www/estimates/nat_90s_1.html.
19. US Census Bureau (b). National population estimates - characteristics. National sex, age, race and Hispanic origin. http://www.census.gov/population/ www/estimates/nat_90s_1.html;
20. http://www.census.gov/popest/national/asrh/NC-EST2005-asrh.html.